Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2026-05-03 @ 6:59 AM
Study NCT ID:
NCT05462457
Status:
RECRUITING
Last Update Posted:
2023-02-15
First Post:
2022-07-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes
Sponsor:
Kliniken Essen-Mitte
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Version 1.0_16.08.2021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None